U-Chart Analysis:ONO PHARMACEUTICAL CO.,LTD.:4528

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index ONO PHARMACEUTICAL CO.,LTD. Go to web site 4528 Medicals 東証プライム March 1, 2000 1962.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

ONO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ONO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 ONO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 ONO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 ONO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 ONO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents 166,141 96,135 69,112 61,045 69,005
Other Current AssetsHelp 247,455 248,966 212,154 186,597 156,217
Tangible Fixed AssetsHelp 104,752 108,420 112,131 113,866 114,628
Intangible Fixed AssetHelp 57,288 69,134 64,734 68,285 66,436
Investments and OthersHelp 338,032 359,782 281,072 315,635 267,158
Total AssetsHelp 913,668 882,437 739,203 745,428 673,444
Total Current LiabilitiesHelp 114,156 133,891 76,796 104,265 104,787
Total Long-term LiabilitiesHelp 6,552 6,678 6,501 7,030 6,173
Shareholder's EquityHelp 792,960 741,868 655,906 634,133 562,484
Total LiabilitiesHelp 913,668 882,437 739,203 745,428 673,444

ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 ONO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales 502,672 447,187 361,361 309,284 292,420
Total Sales 502,672 447,187 361,361 309,284 292,420
Cost of SalesHelp 127,126 110,062 93,511 85,573 79,063
Other Costs and RevenueHelp 247,568 224,402 187,331 148,285 153,653
Total CostsHelp 374,694 334,464 280,842 233,858 232,716
Net RevenueHelp 375,546 337,125 267,850 223,711 213,357
Earnings Before TaxHelp 163,734 143,532 105,025 100,890 79,696
Net IncomeHelp 127,978 112,723 80,519 75,426 59,704
Net Income 127,978 112,723 80,519 75,426 59,704

ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 ONO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help 110,660 159,610 61,829 73,977 74,157
Investing Cash Flow(ICF)Help 48,077 -100,259 6,038 -57,586 -10,234
Financing Cash FlowHelp -89,848 -32,484 -60,237 -24,754 -54,721
Exchange Difference of Cash and Cash EquivalentsHelp 1,116 155 436 403 -179
Net Increase and Decrease in Cash and Cash Equivalentsn 70,005 27,022 8,066 -7,960 9,023

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

ONO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

Immuno-Biological Laboratories Co., Ltd.
KAINOS Laboratories,Inc.
D.Western Therapeutics Institute, Inc.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Modalis Therapeutics Corporation
Eisai Co.,Ltd.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
Mitsubishi Tanabe Pharma Corporation
Tsubota Laboratory Incorporated
FunPep Company Limited